TY - JOUR
T1 - 1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer
AU - Cavaliere, Davide
AU - Cirocchi, Roberto
AU - Coccolini, Federico
AU - Fagotti, Anna
AU - Fambrini, Massimiliano
AU - Federici, Orietta
AU - Lorusso, Domenica
AU - Vaira, Marco
AU - Ceresoli, Marco
AU - Delrio, Paolo
AU - Garofalo, Alfredo
AU - Pignata, Sandro
AU - Scollo, Paolo
AU - Trojano, Vito
AU - Amadori, Andrea
AU - Ansaloni, Luca
AU - Cariti, Giuseppe
AU - De Cian, Franco
AU - De Iaco, Pierandrea
AU - De Simone, Michele
AU - Deraco, Marcello
AU - Donini, Annibale
AU - Fiorentini, Giammaria
AU - Frigerio, Luigi
AU - Greggi, Stefano
AU - Macrì, Antonio
AU - Pasqual, Enrico Maria
AU - Roviello, Franco
AU - Sammartino, Paolo
AU - Sassaroli, Cinzia
AU - Scambia, Giovanni
AU - Staudacher, Carlo
AU - Vici, Patrizia
AU - Vizza, Enrico
AU - Valle, Mario
PY - 2017
Y1 - 2017
N2 - Ovarian cancer (OC) remains relatively rare, although it is among the top 4 causes of cancer death for women younger than 50. The aggressive nature of the disease and its often late diagnosis with peritoneal involvement have an impact on prognosis. The current scientific literature presents ambiguous or uncertain indications for management of peritoneal carcinosis (PC) from OC, both owing to the lack of sufficient scientific data and their heterogeneity or lack of consistency. Therefore, the Italian Society of Surgical Oncology (SICO), the Italian Society of Obstetrics and Gynaecology, the Italian Association of Hospital Obstetricians and Gynaecologists, and the Italian Association of Medical Oncology conducted a multidisciplinary consensus conference (CC) on management of advanced OC presenting with PC during the SICO annual meeting in Naples Italy, on September 10-11, 2015. An expert committee developed questions on diagnosis and staging work-up, indications, and procedural aspects for peritonectomy, systemic chemotherapy, and hyperthermic intraperitoneal chemotherapy for PC from OC. These questions were provided to 6 invited speakers who answered with an evidence-based report. Each report was submitted to a jury panel, representative of Italian experts in the fields of surgical oncology, gynecology, and medical oncology. The jury panel revised the reports before and after the open discussion during the CC. This article is the final document containing the clinical evidence reports and statements, revised and approved by all the authors before submission.
AB - Ovarian cancer (OC) remains relatively rare, although it is among the top 4 causes of cancer death for women younger than 50. The aggressive nature of the disease and its often late diagnosis with peritoneal involvement have an impact on prognosis. The current scientific literature presents ambiguous or uncertain indications for management of peritoneal carcinosis (PC) from OC, both owing to the lack of sufficient scientific data and their heterogeneity or lack of consistency. Therefore, the Italian Society of Surgical Oncology (SICO), the Italian Society of Obstetrics and Gynaecology, the Italian Association of Hospital Obstetricians and Gynaecologists, and the Italian Association of Medical Oncology conducted a multidisciplinary consensus conference (CC) on management of advanced OC presenting with PC during the SICO annual meeting in Naples Italy, on September 10-11, 2015. An expert committee developed questions on diagnosis and staging work-up, indications, and procedural aspects for peritonectomy, systemic chemotherapy, and hyperthermic intraperitoneal chemotherapy for PC from OC. These questions were provided to 6 invited speakers who answered with an evidence-based report. Each report was submitted to a jury panel, representative of Italian experts in the fields of surgical oncology, gynecology, and medical oncology. The jury panel revised the reports before and after the open discussion during the CC. This article is the final document containing the clinical evidence reports and statements, revised and approved by all the authors before submission.
KW - Cancer Research
KW - Combined Modality Therapy
KW - Consensus
KW - Cytoreduction Surgical Procedures
KW - Evidence-Based Medicine
KW - Female
KW - Gynecologic Surgical Procedures
KW - Humans
KW - Hyperthermia, Induced
KW - Hyperthermic intraperitoneal chemotherapy
KW - Italy
KW - Oncology
KW - Ovarian Neoplasms
KW - Ovarian cancer
KW - Peritoneal Neoplasms
KW - Peritoneal carcinosis
KW - Peritonectomy
KW - Cancer Research
KW - Combined Modality Therapy
KW - Consensus
KW - Cytoreduction Surgical Procedures
KW - Evidence-Based Medicine
KW - Female
KW - Gynecologic Surgical Procedures
KW - Humans
KW - Hyperthermia, Induced
KW - Hyperthermic intraperitoneal chemotherapy
KW - Italy
KW - Oncology
KW - Ovarian Neoplasms
KW - Ovarian cancer
KW - Peritoneal Neoplasms
KW - Peritoneal carcinosis
KW - Peritonectomy
UR - http://hdl.handle.net/10807/111311
UR - http://www.tumorijournal.com/attach/10c7ceda-518e-465f-b913-cf358300c0da/5f82a791-caaa-4e4d-b0c9-e6b77412f2ae
U2 - 10.5301/tj.5000623
DO - 10.5301/tj.5000623
M3 - Article
SN - 0300-8916
VL - 103
SP - 525
EP - 536
JO - Tumori
JF - Tumori
ER -